CNBC’s Options Action Trade for Sept 11th, 2017 – Amgen (AMGN)
On Friday’s CNBC’s Options Action, the crew analyzed the performance of Amgen stock. Amgen has been one of the best performing stocks of the S&P500 over the past 30 years. Recently the stock has remained flat over the past 3 years while the market and the healthcare sector has rallied. Amgen has reached the apex of a bullish triangle formation and Carter Worth expects the stock to breakout higher. Expecting a move higher, Michael Khouw suggested buying a Dec 185/200 Call Spread for a $4.50 Debit.
We’ve structured this trade in OptionsPlay so you can analyze and view this trade along with the supporting technical chart at your convenience. You can also view the Options Action’s video by clicking on the following link: CNBC Options Action